This site is intended for UK Healthcare professionals only

Oncology Professional Care 2024
21-22 May at ExCeL London

Oncology Professional Care is the must-attend, multi-disciplinary event delivering free CPD-certified learning for the entire oncology community.

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend this event

2024 Programme

Subpage Hero



Lessons from the SURECAN trial: A new holistic psychological therapy for people living with and beyond cancer

21 May 2024
Living With and Beyond Cancer Theatre

The SURECAN study (Survivors’ Rehabilitation Evaluation after Cancer) is a £2.7 million programme grant funded by the National Institute for Health Research (NIHR) which evaluates a new type of psychological therapy: acceptance and commitment therapy (ACT) plus work and/or physical activity intervention where appropriate called ACT+. Three million people are living with and beyond cancer which is set to increase to 5 million by 2040. One of the three people with a cancer diagnosis has a low quality life. ACT+ combined with a cultural humble approach to reflect the ethnic diversity of the UK, hopes to improve quality of life for people living with and beyond cancer. The sessions provide new insights on how this new therapy was developed, piloted and trialled within the NHS.

Stephanie Taylor, Professor in Public Health and Primary Care - Barts and The London School of Medicine and Dentistry
Imran Khan, Research Programme Manager - Queen Mary University Of London
Trudie Chalder, Professor of Cognitive Behavioural Psychotherapy - King’s College London
Damien Ridge, Professor of Health Studies - University of Westminster